Branched-chain amino acid supplementation as a potential trigger for migraine without aura: a case report Authors: Mehmet Sinan Saricicek, Ali Taylan Saricicek Published: 2026 ABSTRACT AbstractBackgroundMigraine is a common and disabling neurological disorder with a wide range of reported triggers, including dietary factors and nutritional supplements. Branched-chain amino acids (BCAAs) are frequently consumed to enhance athletic performance; however, their potential role in triggering migraine attacks remains largely unexplored.Case presentationA 28-year-old White man developed a severe unilateral pulsatile headache associated with nausea, vomiting, and photophobia 2 hours after consuming a BCAA supplement following exercise. Neuroimaging and laboratory investigations were unremarkable, and the patient fulfilled the International Classification of Headache Disorders, 3rd edition (ICHD-3), criteria for migraine without aura. Symptoms resolved with acute treatment, and no further attacks occurred following discontinuation of BCAA supplementation and implementation of preventive and lifestyle measures during 6 months of follow-up.ConclusionThis case highlights BCAA supplementation as a potential trigger for migraine and discusses plausible neurobiological mechanisms relevant to migraine susceptibility. Further studies are needed to clarify this potential association.Keywords: Migraine, Branched-chain amino acids, Dietary supplements, Headache triggers, Case report Introduction Migraine affects more than one billion individuals worldwide and represents a leading cause of disability among young and middle-aged adults [1]. Despite advances in understanding its neurobiology, the pathophysiology of migraine remains incompletely understood, and attacks are often precipitated by identifiable triggers such as stress, sleep disturbances, environmental factors, and dietary components [2, 3]. Although diet-related triggers are commonly reported, the contribution of nutritional supplements has received comparatively limited attention. Branched-chain amino acids (leucine, isoleucine, and valine) are widely used supplements, particularly among physically active individuals, because of their proposed benefits for muscle metabolism and recovery. Experimental data suggest that BCAAs may influence central neurotransmission through competition with aromatic amino acids at the blood–brain barrier and modulation of glutamatergic signaling, mechanisms potentially relevant to migraine pathophysiology [4, 5]. Case presentation A 28-year-old White man with no history of chronic medical conditions presented with an acute onset of severe unilateral throbbing headache localized to the left periorbital and frontal region, occurring 2 hours after consuming a BCAA supplement for the first time following exercise. The pain progressively worsened over 5 hours, was aggravated by movement, and radiated to the left temporal region. Associated symptoms included nausea, repeated vomiting, photophobia, and phonophobia. He denied visual aura, focal neurological deficits, and autonomic symptoms. He reported a history of six to seven previous mild-to-moderate headaches since adolescence, mostly triggered by emotional stress, sleep deprivation, fasting, and excessive caffeine intake. These episodes were responsive to paracetamol and rest. However, he denied any prior attacks of comparable severity and stated that he had been adequately hydrated and had avoided all previously identified triggers before the current episode. Contrast-enhanced cranial computed tomography, laboratory investigations, and electrocardiography findings were unremarkable, ruling out intracranial pathology such as hemorrhage or space-occupying lesions. Acute treatment with intravenous paracetamol (1 g) and ondansetron (4 mg) resulted in complete symptom resolution, and the patient fulfilled the ICHD-3 diagnostic criteria for migraine without aura [6]. Differential diagnosis The differential diagnosis of severe headache associated with photophobia and vomiting includes serious conditions such as intracranial hemorrhage, space-occupying lesions, aneurysm, and meningitis. The absence of focal neurological deficits and the normal computed tomography findings helped exclude these conditions. Primary headache disorders, including tension-type headache and cluster headache, were also considered. However, tension-type headache typically presents as bilateral pain with a compressive, band-like quality and is generally less severe than migraine; moreover, it is not commonly associated with features such as photophobia and vomiting. Cluster headache, although unilateral and localized around the eye, is characteristically associated with autonomic symptoms such as lacrimation and rhinorrhea, which were absent in this case. Given the patient’s history of previous headaches and the current presentation of unilateral pulsatile headache accompanied by nausea and photophobia, a diagnosis of migraine without aura was established according to the International Headache Society criteria. After excluding previously identified triggers, including sleep deprivation and excessive caffeine intake, the BCAA supplement was considered a possible contributing trigger for the current attack. Treatment For treatment of the acute attack, the patient received intravenous paracetamol (1 g) and ondansetron (4 mg), resulting in symptom relief within 2 hours. For long-term prevention, the patient was prescribed magnesium (400 mg daily) and vitamin B2 (400 mg daily), consistent with current migraine prevention guidelines. Outcome and follow-up The patient was instructed to maintain a migraine diary and record foods or events associated with headache episodes. A detailed list of foods to avoid was provided and explained thoroughly. He was advised to maintain a regular sleep schedule and ensure at least 7.5 hours of sleep daily. In addition, he was advised to limit caffeine intake and avoid caffeine-containing beverages after 5 PM. Discontinuation of BCAA supplementation was also recommended. Considering the environmental exposure to prolonged hot weather exceeding 35 °C during several months of the year, additional lifestyle modifications were recommended, including avoidance of excessive heat and reduction of prolonged sunlight exposure. FL-41 filtered glasses were suggested as a supportive measure. Because the patient also reported clinically significant anxiety and occupational stress, escitalopram (10 mg daily) was initiated for anxiety management, and stress reduction techniques were explained in detail. Paracetamol (1 g) was recommended for acute headache attacks as needed. Due to a history of bruxism, the patient was referred to a dentist for regular evaluation and was advised to use a night guard to prevent enamel wear and dental cracks. It was further suggested that, if stress reduction measures and magnesium supplementation failed to alleviate jaw muscle tension, additional interventions such as muscle relaxants or masseter botulinum toxin injections could be considered in consultation with the dentist. The patient was advised to continue regular physical activity while paying attention to hydration, exercise intensity, and environmental factors such as temperature. He was encouraged to maintain a healthy diet, and detailed information regarding the potential adverse effects of all prescribed medications was provided. The patient was monitored monthly for 6 months and did not experience any further migraine attacks. He adhered successfully to the recommended lifestyle modifications, and his anxiety symptoms improved. At follow-up visits, he reported no recurrent attacks and expressed satisfaction with the management plan. Discussion Because the episode occurred following physical exertion, factors such as intense exercise, fasting, hot weather, and dehydration could also have contributed as potential triggers. In addition, sleep deprivation, excessive caffeine intake, and stress had triggered the patient’s previous attacks. However, because the patient denied exposure to these known triggers before the current episode, a possible association between BCAA supplementation and migraine without aura was considered more carefully. Nutritional supplements are not routinely emphasized during headache assessment despite their widespread use among physically active individuals [3, 7]. The temporal relationship, symptom resolution following discontinuation, and the lack of a more convincing alternative explanation support a possible association. BCAAs compete with aromatic amino acids such as tryptophan and tyrosine for transport across the blood–brain barrier, potentially altering central serotonin and dopamine synthesis, neurotransmitter systems implicated in migraine pathophysiology [4, 8]. Furthermore, BCAA-related metabolic alterations may enhance glutamatergic neurotransmission and cortical excitability, thereby lowering the threshold for migraine attacks (Fig. 1). Hypothesized mechanisms linking branched-chain amino acid supplementation to migraine susceptibility. BCAAs may compete with aromatic amino acids at the blood–brain barrier, alter central neurotransmitter synthesis, and increase glutamatergic excitability, thereby lowering the migraine threshold in susceptible individuals According to the Naranjo Adverse Drug Reaction Probability Scale, the association may be classified within the possible-to-probable range. Rechallenge was not performed because of ethical considerations. This case highlights the importance of systematic supplement history-taking and suggests that BCAA supplementation may represent a modifiable migraine trigger. In conclusion, BCAA supplementation may represent a potential trigger for migraine attacks in susceptible individuals. This case reinforces the heterogeneity of migraine presentations and highlights the importance of individualized management strategies. Furthermore, it emphasizes the need for clinicians to consider both common and uncommon dietary triggers when evaluating patients with migraine. Further research is warranted to clarify the mechanisms by which BCAAs may contribute to migraine pathogenesis and to optimize both pharmacological and non-pharmacological treatment approaches. Take-away lessons/learning points Migraine is a complex neurological disorder that can cause severe headache accompanied by vomiting and photophobia. The clinical presentation may mimic serious conditions such as intracranial hemorrhage, brain tumors, aneurysm, meningitis, and encephalitis. Therefore, exclusion of life-threatening causes is essential in every patient presenting with severe headache associated with vomiting and photophobia. Migraine is a complex neurological disorder that can cause severe headache accompanied by vomiting and photophobia. The clinical presentation may mimic serious conditions such as intracranial hemorrhage, brain tumors, aneurysm, meningitis, and encephalitis. Therefore, exclusion of life-threatening causes is essential in every patient presenting with severe headache associated with vomiting and photophobia. Migraine is primarily a clinical diagnosis. Computed tomography (CT) is mainly used to exclude alternative diagnoses. A thorough clinical history, including previous attacks and family history, is crucial for accurate diagnosis and appropriate management. Migraine is primarily a clinical diagnosis. Computed tomography (CT) is mainly used to exclude alternative diagnoses. A thorough clinical history, including previous attacks and family history, is crucial for accurate diagnosis and appropriate management. It is important to inquire about potential triggers, including specific foods, sleep patterns, caffeine intake, alcohol consumption, stress, and environmental exposure. Maintaining a migraine diary is valuable for identifying potential triggers and facilitating individualized prevention and treatment strategies. It is important to inquire about potential triggers, including specific foods, sleep patterns, caffeine intake, alcohol consumption, stress, and environmental exposure. Maintaining a migraine diary is valuable for identifying potential triggers and facilitating individualized prevention and treatment strategies. Common migraine triggers include stress, missed meals, weather changes, sleep disturbances, strong odors or perfumes, and alcohol consumption. Common migraine triggers include stress, missed meals, weather changes, sleep disturbances, strong odors or perfumes, and alcohol consumption. Lifestyle modifications, maintenance of a migraine diary, preventive treatment, and stress management strategies are essential components of migraine management. Lifestyle modifications, maintenance of a migraine diary, preventive treatment, and stress management strategies are essential components of migraine management. Strengths and limitations This case report highlights BCAA supplementation as a possible and underrecognized trigger for migraine. The main limitations include the presentation of a single case and the inability to perform a rechallenge while excluding all other potential triggers because of ethical considerations. Acknowledgements Not applicable. Author contributions All authors contributed equally to this work. Funding This work received no specific funding from any organization. Data availability The data supporting the findings of this case report are included in this published article. Additional data are available from the corresponding author upon reasonable request, subject to patient confidentiality. Declarations Ethics approval and consent to participate This is a single-patient case report and does not involve experimental intervention or identifiable personal data beyond standard clinical care. Written informed consent was obtained from the patient for publication of this case report and accompanying images in accordance with the Declaration of Helsinki. Consent for publication Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests The authors declare that they have no known competing financial or non-financial interests that could have appeared to influence the work reported in this paper. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data supporting the findings of this case report are included in this published article. Additional data are available from the corresponding author upon reasonable request, subject to patient confidentiality.